TEM
Tempus AI, Inc. NASDAQ Listed Jun 14, 2024$50.84
+4.20%
vs $48.79
Mkt Cap $8.9B
52w Low $41.73
14.6% of range
52w High $104.32
50d MA $49.93
200d MA $64.26
P/E (TTM)
-36.1x
EV/EBITDA
—
P/B
18.0x
Debt/Equity
1.7x
ROE
-49.9%
P/FCF
-37.0x
RSI (14)
50.60
ATR (14)
$3.99
Beta
4.90
50d MA
$49.93
200d MA
$64.26
Avg Volume
7.2M
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
600 West Chicago Avenue · Chicago, IL 60654 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.21 | -0.13 | +38.1% | 54.07 | -6.0% | -1.1% | -7.5% | +0.8% | -2.8% | -3.1% | — |
| Feb 24, 2026 | AMC | -0.04 | -0.04 | +8.7% | 57.95 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% | — |
| Nov 4, 2025 | AMC | -0.17 | -0.11 | +36.2% | 84.49 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% | — |
| Aug 8, 2025 | AMC | -0.23 | -0.22 | +4.3% | 60.87 | -1.4% | -0.1% | +9.1% | +5.0% | +2.8% | +3.1% | — |
| May 6, 2025 | AMC | -0.26 | -0.24 | +7.7% | 52.19 | -0.1% | +12.6% | +11.0% | -5.9% | +2.2% | +9.9% | — |
| Feb 24, 2025 | AMC | -0.15 | -0.18 | -20.0% | 69.57 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% | — |
| Nov 4, 2024 | AMC | -0.27 | -0.25 | +6.1% | 49.50 | -1.4% | -10.1% | +28.0% | -0.3% | +29.9% | +5.2% | — |
| Aug 6, 2024 | AMC | -0.59 | -0.63 | -6.8% | 40.65 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% | — |
| Jun 17, 2024 | AMC | — | -0.38 | — | 36.48 | +1.4% | -16.9% | -10.1% | +5.1% | -11.6% | -1.4% | — |
| Dec 31, 2023 | AMC | — | -0.30 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.31 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | -0.33 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | -0.32 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2 | Wolfe Research | Reiterates | Peer Perform | — | $52.80 | $51.50 | -2.5% | -6.0% | -4.3% | +10.0% | -11.2% | +4.7% |
| Mar 30 | Guggenheim | Maintains | Buy → Buy | — | $42.62 | $42.36 | -0.6% | -0.6% | +6.7% | +4.0% | +0.8% | -0.2% |
| Mar 11 | Needham | Maintains | Buy → Buy | — | $50.90 | $51.54 | +1.3% | +3.5% | -6.0% | +0.9% | +1.8% | -0.1% |
| Mar 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $52.26 | $50.89 | -2.6% | +0.1% | -2.7% | +3.5% | -6.0% | +0.9% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $53.31 | $51.13 | -4.1% | -3.6% | -0.2% | +3.4% | -1.5% | +0.1% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Feb 25 | JP Morgan | Maintains | Neutral → Neutral | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Feb 25 | BTIG | Maintains | Buy → Buy | — | $57.95 | $57.08 | -1.5% | -7.3% | +3.2% | -3.9% | +0.1% | -3.6% |
| Dec 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $64.46 | $66.36 | +2.9% | +2.3% | -1.8% | -0.7% | -2.4% | -2.0% |
| Dec 15 | JP Morgan | Maintains | Neutral → Neutral | — | $70.61 | $70.53 | -0.1% | -2.7% | -0.8% | -5.1% | -3.7% | +3.6% |
| Dec 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $74.07 | $74.60 | +0.7% | -0.1% | +1.3% | +1.9% | +0.4% | +0.5% |
| Nov 25 | BTIG | Maintains | Buy → Buy | — | $76.06 | $76.01 | -0.1% | +1.0% | +0.5% | +0.9% | -5.0% | -0.1% |
| Nov 11 | Piper Sandler | Maintains | Neutral → Neutral | — | $71.78 | $71.60 | -0.3% | -0.3% | -0.6% | -4.4% | +0.8% | -3.1% |
| Nov 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $71.78 | $71.60 | -0.3% | -0.3% | -0.6% | -4.4% | +0.8% | -3.1% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $72.09 | $71.35 | -1.0% | -0.7% | +0.3% | -0.3% | -0.6% | -4.4% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Nov 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Nov 5 | Needham | Maintains | Buy → Buy | — | $84.49 | $82.23 | -2.7% | -2.6% | -12.4% | -0.7% | +0.3% | -0.3% |
| Oct 22 | Piper Sandler | Maintains | Neutral → Neutral | — | $89.10 | $90.60 | +1.7% | -4.3% | +2.1% | +2.5% | +2.6% | -5.4% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $89.10 | $90.60 | +1.7% | -4.3% | +2.1% | +2.5% | +2.6% | -5.4% |
| Sep 26 | Guggenheim | Maintains | Buy → Buy | — | $77.33 | $78.71 | +1.8% | +1.5% | +0.1% | +2.7% | +9.0% | +1.5% |
| Sep 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $88.78 | $89.26 | +0.5% | -2.7% | -1.4% | +2.2% | -0.7% | +0.7% |
| Aug 20 | BTIG | Maintains | Buy → Buy | — | $73.08 | $70.77 | -3.2% | +0.3% | +4.7% | +5.0% | -5.7% | +0.5% |
| Aug 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $60.82 | $61.35 | +0.9% | +9.1% | +5.0% | +2.8% | +3.1% | +6.3% |
| Jul 29 | BTIG | Maintains | Buy → Buy | — | $62.00 | $61.05 | -1.5% | -6.0% | -0.8% | -2.1% | -3.0% | +4.8% |
| Jun 30 | Guggenheim | Maintains | Buy → Buy | — | $66.52 | $65.69 | -1.2% | -4.5% | -6.4% | -0.5% | +3.0% | -4.9% |
| Jun 25 | BofA Securities | Maintains | Neutral → Neutral | — | $68.28 | $69.58 | +1.9% | -4.1% | +4.4% | -2.7% | -4.5% | -6.4% |
| May 15 | Piper Sandler | Maintains | Neutral → Neutral | — | $64.78 | $64.80 | +0.0% | -3.4% | +4.6% | -2.7% | -2.1% | -6.9% |
| May 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $65.22 | $66.26 | +1.6% | -5.9% | +2.2% | +9.9% | -6.0% | -3.4% |
| May 7 | Needham | Maintains | Buy → Buy | — | $52.19 | $52.13 | -0.1% | +12.6% | +11.0% | -5.9% | +2.2% | +9.9% |
| Apr 24 | Needham | Maintains | Buy → Buy | — | $49.55 | $50.40 | +1.7% | +8.0% | -1.1% | +1.6% | +1.0% | -4.8% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $43.79 | $42.85 | -2.1% | -8.0% | +4.5% | +2.4% | -0.5% | -4.8% |
| Mar 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $53.06 | $50.47 | -4.9% | -7.9% | +0.5% | -8.0% | +0.9% | -0.2% |
| Mar 4 | Piper Sandler | Maintains | Neutral → Neutral | — | $50.93 | $48.59 | -4.6% | +3.5% | +0.6% | -7.9% | +0.5% | -8.0% |
| Mar 3 | BofA Securities | Maintains | Neutral → Neutral | — | $56.18 | $57.55 | +2.4% | -9.3% | +3.5% | +0.6% | -7.9% | +0.5% |
| Feb 25 | JP Morgan | Downgrade | Overweight → Neutral | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 25 | Guggenheim | Maintains | Buy → Buy | — | $69.57 | $58.49 | -15.9% | -15.0% | +5.3% | -11.2% | +1.6% | -9.3% |
| Feb 12 | William Blair | Downgrade | Outperform → Market Perform | — | $71.21 | $68.43 | -3.9% | +3.7% | +13.4% | +6.8% | -8.4% | +4.6% |
| Jan 14 | Loop Capital | Maintains | Buy → Buy | — | $32.34 | $33.10 | +2.4% | -1.6% | +9.7% | -0.5% | +1.2% | +35.5% |
| Jan 14 | Needham | Maintains | Buy → Buy | — | $32.34 | $33.10 | +2.4% | -1.6% | +9.7% | -0.5% | +1.2% | +35.5% |
| Dec 13 | BofA Securities | Maintains | Neutral → Neutral | — | $41.99 | $42.00 | +0.0% | -2.4% | -2.7% | -2.3% | -11.9% | -3.7% |
| Nov 12 | Piper Sandler | Maintains | Neutral → Neutral | — | $77.62 | $76.20 | -1.8% | -12.3% | +0.1% | -16.8% | -7.5% | +3.2% |
| Nov 11 | Stifel | Downgrade | Buy → Hold | — | $73.77 | $69.78 | -5.4% | +5.2% | -12.3% | +0.1% | -16.8% | -7.5% |
| Oct 15 | Loop Capital | Maintains | Buy → Buy | — | $50.72 | $50.72 | +0.0% | -8.1% | +5.2% | -2.1% | +2.8% | -1.3% |
| Oct 2 | BofA Securities | Downgrade | Buy → Neutral | — | $53.07 | $52.50 | -1.1% | -3.4% | -4.5% | +8.1% | -4.5% | -4.9% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $40.65 | $39.91 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $40.65 | $39.91 | -1.8% | -4.5% | +0.3% | -0.5% | -0.2% | +10.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Epstein David R | — | Sell | 250 | $49.40 | $12K | 31,464 | +10.00% | +1.35% |
| May 27, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 97,279 | $46.89 | $4.6M | 15,523,469 | +4.62% | -11.16% |
| May 27, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 35,721 | $46.17 | $1.6M | 15,620,748 | +4.62% | -11.16% |
| May 27, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 24,318 | $46.89 | $1.1M | 8,808,533 | +4.62% | -11.16% |
| May 27, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 8,932 | $46.17 | $412K | 8,832,851 | +4.62% | -11.16% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 27,570 | $51.52 | $1.4M | 15,656,469 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 105,430 | $51.03 | $5.4M | 15,684,039 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 6,890 | $51.52 | $355K | 8,841,783 | -0.87% | -7.53% |
| Apr 28, 2026 | LEFKOFSKY ERIC P | CEO and Chairman | Sell | 26,360 | $51.03 | $1.3M | 8,848,673 | -0.87% | -7.53% |
8-K
Tempus AI, Inc. -- 8-K Filing
May 22
8-K
Tempus AI, Inc. -- 8-K Filing
May 13
8-K · 7.01
! Medium
Tempus AI, Inc. -- 8-K 7.01: Regulation FD Disclosure
Tempus AI disclosed supplemental 2025 financial information and a management letter via its investor relations website, providing additional transparency into fourth-quarter and full-year performance.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Ark Investment Management Llc | 9,607,745 | $434M | Added | Mar 2026 |
| 2 | Gc Wealth Management Ria, Llc | 6,761,507 | $399M | New | Dec 2025 |
| 3 | Morgan Stanley | 4,166,788 | $246M | Reduced | Dec 2025 |
| 4 | Softbank Group Corp. | 5,405,406 | $244M | — | Mar 2026 |
| 5 | Vanguard Capital Management Llc | 4,918,122 | $222M | New | Mar 2026 |
| 6 | Vanguard Portfolio Management Llc | 4,679,057 | $212M | New | Mar 2026 |
| 7 | Jpmorgan Chase & Co | 4,933,193 | $209M | — | Mar 2026 |
| 8 | Ubs Group Ag | 3,234,387 | $146M | Added | Mar 2026 |
| 9 | Franklin Resources Inc | 2,581,644 | $117M | Added | Mar 2026 |
| 10 | Alphabet Inc. | 1,551,102 | $92M | — | Dec 2025 |
| 11 | Lingotto Investment Management Llp | 1,415,766 | $64M | Added | Mar 2026 |
| 12 | Marex Group Plc | 821,327 | $37M | Added | Mar 2026 |
| 13 | Two Sigma Investments, Lp | 799,398 | $36M | Reduced | Mar 2026 |
| 14 | Barclays Plc | 669,675 | $30M | Added | Mar 2026 |
| 15 | Citadel Advisors Llc | 601,305 | $27M | Reduced | Mar 2026 |
| 16 | Northern Trust Corp | 500,451 | $23M | Added | Mar 2026 |
| 17 | Marshall Wace, Llp | 496,508 | $22M | Reduced | Mar 2026 |
| 18 | Ilex Capital Partners (Uk) Llp | 454,217 | $21M | New | Mar 2026 |
| 19 | Patient Capital Management, Llc | 442,199 | $20M | Added | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 414,780 | $19M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$8.87B
Enterprise Value
$8.91B
P/E (TTM)
-36.06x
Forward P/E
—
PEG Ratio
0.61x
P/B
18.03x
P/S
6.97x
P/FCF
-37.05x
EV/EBITDA
—
Shares Out
174.3M
Financials (TTM)
Revenue
$1.27B
Net Income
-$245.0M
EBITDA
-$222.4M
Free Cash Flow
-$239.1M
Op Cash Flow
-$218.1M
EPS Basic
$-1.41
EPS Diluted
$-1.41
EPS Forward
$-0.43
Gross Margin
69.6%
Op Margin
-18.8%
Net Margin
-19.3%
Balance Sheet
Total Assets
$2.27B
Total Liab.
$1.78B
Total Equity
$491.3M
Cash
$755.0M
LT Debt
$802.4M
Book Value/Sh
$2.82
Debt/Equity
1.66x
Current Ratio
3.13
Quick Ratio
3.00
Returns & Growth
ROE
-49.9%
ROA
-10.8%
ROIC
-10.3%
Rev Growth YoY
+83.4%
EPS Growth YoY
+69.3%
Price Returns
2W
+11.0%
1M
-9.0%
3M
-5.2%
6M
-35.2%
12M
-8.5%
Technicals
52W High
$104.32
52W Low
$41.73
50d MA
$49.93
200d MA
$64.26
RSI (14)
50.60
ATR (14)
$3.99
Beta
4.90
Avg Volume
7.2M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
Jul 18, 2006
Analyst Price Targets
Consensus
$83.43
High
$105.00
Low
$59.00
Median
$85.00
Data updated apr 27, 2026 4:26am
· Source: financialmodelingprep.com